Please assess the completion status of the following clinical trial:

Trial Title: Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 2 tattoos no larger than 25cm2, professionally made, with approximately the same age, containing blue/black ink.~Exclusion Criteria:~* Hypersensitivity to imiquimod~* Current sun tan~* Use of vitamin E, non-steroid anti-inflammatory drugs, coumadin or aspirin for the past 10 days~* Amateur tattoos~* Pregnancy~* Breast-feeding status~* Immunosuppression~* Auto-immune diseases.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): The tattoo will be treated with laser and imiquimod 5% cream
- 2 (Type: PLACEBO_COMPARATOR): The tattoo will be treated with laser and placebo topical cream

Based on this trial design, predict the completion outcome and termination type (if applicable).